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Abstract: 
Dose structures are basically pharmaceutical items in the structure in which they are showcased for use, normally 
including a blend of dynamic medication parts and nondrug segments (excipients), alongside other non-reusable 
material that may not be considered either fixing or bundling, (for example, a container shell, for instance). The 
term unit measurements can now and then envelop non-reusable bundling too (particularly when every medication 
item is exclusively packaged. Different measurements structures might exist for a solitary specific medication, since 
various medicinal conditions can warrant distinctive courses of organization. For instance, steady queasiness and 
heaving might make it hard to utilize an oral dose structure, and in such a case, it might be important to use a 
backup course of action, for example, inhalational, buccal, sublingual, nasal, suppository or parenteral. The 
primary objective was in vitro comparative study of 5 different brands of Ciprofloxacin Tablets available in markets 
of Pakistan by The in vitro comparative study of 5 different brands of Ciprofloxacin Tablets available in markets of 
Pakistan 
Weight variation Test, Disintegration Test, Hardness Test, Chemical Assay and In vitro dissolution study was 
conducted. After conducting color, friability, weight variation, hardness test and disintegration tests of various 
brands of Ciprofloxacin, the results were found under the acceptance range. The hardness showed variation among 
the tablets of various brands but there was no significant variation of hardness among the tablets of same brand. 
The Axcin indicated maximum drug potency (102%) and (101%) respectively while minimum potency was 93.07%. 
The in-vitro evaluation of 5 different F.P.Ps of Ciprofloxacin HCl film coated tablets available in the 
pharmaceutical market of Pakistan showed that all of brands of Ciprofloxacin satisfied the USP potency 
specifications and showed evidences of satisfactory initial in-vitro dissolution behavior. 
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INTRODUCTION: 
The generic drugs are made available to 
health care system in many developing 
countries [1] That’s to improve the 
healthcare drug availability and delivery in 
developing countries but in addition to 
benefits it also accompanied by a lot of 
issues among which substandard drugs 
distribution in crucial one [2]. The drugs 
monitoring includes all procedures 
performed in obtaining relatively more and 
more data regarding product after it has got 
authorization for marketing and made 
publicly available for use and these that 
gotten from different procedures can be used 
for making standards [3], regulations and for 
improvement in product [2]. As the 
regulatory authorities depends upon limited 
information that are obtained from trials 
(clinical) and from other literatures for 
allowing and it is very important to monitor 
the medicines (approved) for its therapeutic 
effectiveness and Quality of medicines that 
are used by large population [4]. The 
medication significance in increasing patient 
satisfaction and lowering mortality may not 
be overemphasized like as low-quality 
medicines are relatively unsafe and also 
increase in treatment cost due to the 
medication having low quality [5]. 
Therefore, testing the drugs in laboratory in 
routine basis is important to save health of 
public especially in countries that are 
developing. World Health organization has 
already issued guidelines for requirements, 
quality control and registration of generic 
drugs [6]. The innovator drug’s efficacy, 
safety and quality standards must also be 
satisfied by generic drugs [2]. Poor practices 
of quality control and concerned regulatory 
authorities has allowed presence of low 
Quality medicines in market [7]. It may have 
many causes as decomposition of main 
ingredient from drug due to storage 
conditions like humidity and temperature 
and also poor quality assurance during drug 
manufacturing [8]. 
The objective of present study was analysis 
of Quality control and to assess different 
brands of Ciprofloxacin that are available in 
market. 
 
MATERIAL AND METHODS: 
Five different brands of ciprofloxacin HCl 
(Axcin, Mytil, Nafcin, Oxirase And Quash) 
film coated tablets in which one brand is 
innovator (Axcin) and other four brands are 
generics, each of 500 mg available in 
Pakistani pharmaceutical market were 
evaluated. 
UV-Visible Spectrophotometer (Model No. 
1601, Schimadzu, Japan), Mosanto tablet 
hardness tester (Mosanto UK), Erweka 
disintegrating chamber, Orion Research 
analogue pH meter model 301, Siliconizad 
glass test tubes, Digital analytical balance 
(Model No. Ax-200. Schimadzu Japan.), 
Volumetric flasks, Conical flasks, glass 
funnels, test tubes (Pyer glass, scott), Sterile 
(pyrogen free disposable syringes(Otsuka), 
Pharma Test Dissolution Apparatus, PTWS 
– 11/P, TPT (Germany), Stability Chamber, 
Oven Memert Model U-30, 854 Schwabach 
(Germany). 
 
Weight variation and disintegration test 
Twenty tablets of each brand were weighed 
individually and calculated the average 
weight of tablet. Maximum and minimum 
values for weight were noted. USP limits for 
weight variation test were applied to 
evaluate the data.  
 
USP specifications were applied for 
disintegration test with a constant frequency 
(speed) rate 32 c.p.m (speed limit is 29-32 
c.p.m as per USP specification) at 
temperature of 37 C°. (Temperature limit is 
35 C° -39 C°as per USP specifications). As 
the disintegration test was carried out for the 
film-coated tablets so it was performed in 
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two steps using following two different 
Medias. 
 
1. Water: The tablets were first immersed in 
water for five minutes prior to disintegration 
to dissolve the film coat of the tablets. 
 
2. 0.1 N HCl:  After dissolving the coat of 
the tablet, it was placed in the disintegration 
apparatus using 0.1 N HCl as disintegration 
medium. Six tablets of each brand of 
Ciprofloxacin and were taken and the mean 
disintegration time (in minutes) was 
calculated. If the test was failed for these 
first six tablets then the test was performed 
for other twelve tablets of each brand of 
Ciprofloxacin in two rounds, six tablets in 
each round. USP tolerance was applied to 
evaluate the results obtained. 
 
Hardness Test/Crushing Strength:  
Twenty tablets of each brand were selected 
randomly and subjected to hardness test. 
The range of crushing strength was noted. 
The instrument showed the force of breaking 
in Newton, which were converted in 
Kg/cm2. After that the results obtained were 
evaluated using USP tolerance limits. 
 
Chemical Assay of Ciprofloxacin Tablets:  
The assay for the active ingredients in the 
Ciprofloxacin HCl film coated tablets was 
performed using UV-Visible 
spectrophotometer. The chemical assays 
were repeated three times and results are 
presented as the mean of three 
determinations. 
 
Standard Preparation: Weight of the 
Ciprofloxacin HCl equivalent to 100 mg of 
Ciprofloxacin base were calculated as 
follow, 
=   Molecular Weight of Ciprofloxacin 
Monohydric chloride Monohydrate ×100 
Molecular weight of Ciprofloxacin base 
So, 116.4 mg of Ciprofloxacin HCl 
equivalent to 100 mg of Ciprofloxacin base 
were calculated and were used during 
standard solution preparation for assay of 
the tablets. 
 
The calculations were made on the basis of 
weight of Ciprofloxacin HCl equivalent to 
Ciprofloxacin base. 
 
Powder of standard Ciprofloxacin HCl 
equivalent to 100 mg of Ciprofloxacin base 
were weighed accurately with the help of 
electronic balance. This amount of powder 
of respected drugs was transferred to 100 ml 
of volumetric flask in which small amount 
of 0.1 N HCl was added to dissolve 
Ciprofloxacin HCl powder. It was sonicated 
well for 20 minutes to get clear solution. 
The volume was made upto 100 ml with 0.1 
N HCl in the volumetric flask and was 
mixed. 
 
Sample Preparation: Twenty tablets of 
Ciprofloxacin 500mg were taken and 
crushed into powder form. Then these 
powders were sieved through 100 mesh and 
weighed accurately with the help of digital 
electronic balance .Average weight for a 
single tablet was determined by dividing the 
total weight of sieved powder by total 
number of tablets. 
 
Weight for a single tablet equivalent to 
100mg of active Ciprofloxacin was 
calculated as follows. 
Equivalent weight of tablet of Ciprofloxacin =       
Average weight of single tablet  ×100 
 Total weight of active ingredient in tablet 
 
Now powder equivalent to 100 mg of active 
(Ciprofloxacin as base) were weighed and 
taken in 100ml volumetric flask and then a 
small quantity of 0.1 N HCl solution was 
added to dissolve the given quantity of 
powder. After that the volume was made up 
to mark by adding 0.1 N HCl solution. The 
solution was stirred for 20 minutes to 
dissolve and mixed it completely. This 
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solution was filtered in conical flask. One ml 
of filtrate was taken in a 100 ml volumetric 
flask. 
Analysis: Absorbance of sample solution 
and standard solution were measured at 
λmax.276nm on UV-Visible 
Spectrophotometer using 0.1 N HCl as 
blank. 
In vitro dissolution study:   
Dissolution of tablets of Ciprofloxacin were 
carried in the following two Medias. 
 
1. Distilled Water 
 
2. 0.1 N HCl Solution  
0.1 N HCl was also used as a dissolution 
medium for dissolution tests to determine the 
influence of tropical climate storage conditions 
on the quality of tablets which is a major part of 
my current project. 
 
Calibration curve for Ciprofloxacin HCl in 
Distilled water: forty mg of standard grade 
Ciprofloxacin HCl powder were accurately 
weighed with the help of digital electronic 
balance and after weighing transferred to 100 ml 
volumetric flasks. It was dissolved in small 
quantity of distilled water and then sonicated for 
20 minutes to get a stock clear solution .This 
solution was  diluted with addition of distilled 
water in sufficient quantity to make the volume 
up to the mark. So aqueous solution of 
Ciprofloxacin having 0.4 mg/ml concentration 
was prepared which was used as stock solution 
.Different volumes of stock solution were taken 
in 100 ml flask and each volume this solution 
was diluted by making the volume up to 100 ml 
with corresponding dissolution medium 
(Distilled water) to get solutions of 
Ciprofloxacin HCl of 0.008, 0.01, 0.012, 0.014, 
0.016, 0.018 and 0.02 mg/ml. These solutions 
were analyzed with UV-Visible 
Spectrophotometer at λmax 276nm while using 
distilled water as blank solution. Three readings 
were noticed for each dilution and mean of these 
three readings was calculated for the respective 
concentration. A calibration curve was 
constructed by plotting absorbance versus 
concentrations which gave an equation of y= 
87.597×-0.0079 with coefficient of variation 
(R2) of 0.9999 (n=7). 
 
Calibration curve for Ciprofloxacin HCl in 
0.1 N HCl: Calibration curve for Ciprofloxacin 
HCl was also constructed in 0.1 N HCl solutions 
by following the same procedure  
As described above for calibration curve of 
Ciprofloxacin HCl in Distilled Water except 
0.1N HCl was used as solvent in this case. The 
equation obtained was y= 122.49 ×+0.0004 with 
a coefficient of variation (R2) 0.9997 in this 
case. Unknown concentrations of Ciprofloxacin 
HCl were determined using regression equation. 
Y=MC+B 
 
Where Y= absorbance of solution containing 
Ciprofloxacin HCl at λ max 276nm. 
M= Slope of Ciprofloxacin HCl Standard curve 
of Known concentrations. 
C= concentration to Calculate 
B= Intercept of curve 
After rearranging the above equation we got: 
C= (Y-B)/M   
 
Dissolution tests for Ciprofloxacin HCl were 
performed using the USP paddle method 
(Apparatus II) at speed of 50rpm. The volume of 
dissolution medium in each vessel was 900 ml, 
maintained at a temperature of 37.0 ±0.5 C°.  
Aliquots (5ml) of the dissolution medium were 
withdrawn at interval of 5,15,30,45 and 60 
minutes. The samples were withdrawn manually 
using a 5ml syringe from each vessel of the 
dissolution apparatus. After each sampling equal 
volume of dissolution medium was added to 
each vessel as replacement solution. The 
dissolution samples were diluted with the 
dissolution medium (1:50) so as to get 
absorbance in the linear range of the Lambert-
Beer Law and were analyzed by UV-Visible 
spectrophotometer at λmax 276nm. After 
calculating the results for dissolution profiles of 
the finished pharmaceutical products of 
Ciprofloxacin in both of the dissolution media 
(D/W and 0.1 N HCl) these were also compared 
with each other. 
 
Statistical Calculation: The profiles of 
formulations that met these requirements were 
further evaluated using Weilbur function 
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models, a Model Independent Approach using a 
Similarity Factor (f2) as recommended by the 
FDA for the comparison of the dissolution 
profiles of immediate release dosage forms .[87] 
In this study ,the dissolution profile of the test 
formulation obtained was compared with the 
dissolution characteristics of the reference 
formulation *(innovator brand Axcin) obtained. 
As the dissolution studies were performed in two 
different media hence the f2 was calculated for 
the tablet dissolution profiles in both media. The 
f2 values thus obtained from dissolution in D/W 
was compared with obtained from the tablet 
dissolution in 0.1 N HCl to determine the 
similarity of their dissolution behavior in the 
corresponding medium .The similarity factor  
was computed using the equation by Moore and 
Flanner recommended by the FDA(51). 
 
 
 
 
 
Where Rt and Tt are the percentages of drug 
dissolved at time t (for t=1, 2, …..n), of the 
reference and test formulation respectively. The 
measurements at each time point were weighed 
according to its importance in the dissolution 
curve using wt as an optional weight factor. As 
all time points were equal so wt was assigned 
value 1. The profiles of F.P.Ps were considered 
similar/pharmaceutically equivalent showing 
less than 10% average difference at any sample 
time point, corresponding to a similarity factor 
(f2) greater or equal to 50. 
RESULTS AND DISCUSSION: 
Table 1. Shows the results of quality control 
tests of all the selected brands of finished 
pharmaceutical products Ciprofloxacin. 
After conducting colour, friability, weight 
variation, hardness test and disintegration 
tests of various brands of Ciprofloxacin, the 
results were found under the acceptance 
range. The hardness showed variation 
among the tablets of various brands but 
there was no significant variation of 
hardness among the tablets of same brand. 
The maximum hardness was observed for 
MYTIL While NAFCIN Showed minimum 
hardness among all the formulations of 
Ciprofloxacin. The disintegration time test 
showed appreciable differences for different 
brands of Ciprofloxacin. No co-relation was 
observed between hardness and 
disintegration time of the formulations. The 
divergence in the hardness, weight and 
disintegration time test values may due to 
differences in the manufacturing procedure 
or in the quantity and quality of the 
materials used in the formulations. 
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Table: 1- Quality control tests of Five F.P.Ps of Ciprofloxacin 
Room temperature 
F.P.P Time Colour Hardness Friability Weight variation Disintegration assay 
AXCIN 
 
0 month White 8.4 0.1 740.98 10 102.320% 
3 month White 8.4 0.1 740.70 10 101.200 
6 month White 8.3 0.1 739.70 10 100.127 
MYTIL 
 
0 month White 5.4 0.4 803.10 12 100.789 
3 month White 5.2 0.4 802.92 12 100.140 
6 month White 5.1 0.4 802.95 13 99.124 
NAFCIN 
 
0 month White 10.17 0.31 780.75 18 97.281 
3 month White 10.2 0.39 779.95 18 96.200 
6 month White 10.4 0.38 779.40 19 96.142 
OXIRASE 
0 month White 7.9 0.53 723.16 11 99.035 
3 month White 7.4 0.54 722.75 11 98.765 
6 month White 7.3 0.55 721.62 12 97.576 
QUASH 
0 month White 6.53 0.42 777.52 25 96.930 
3 month White 6.43 0.40 780.08 25 96.132 
6 month White 6.21 0.43 775.65 25 95.768 
Accelerated Temperature 
FPP TIME Color Hardness Friability Weight variation disintegration Assay 
AXCIN 
 
0 month White 8.37 0.1 740.70 10 101.920% 
3 month White 8.23 0.1 740.40 10 101.143 
6 month White 8.20 0.1 740.34 10 100.045 
MYTIL 
 
0 month White 5.36 0.38 801.65 12 99.978 
3 month White 4.95 0.37 801.80 12 99.041 
6 month White 4.90 0.36 801.25 13 98.980 
NAFCIN 
 
0 month White 10.1 0.3 775.54 19 97.045 
3 month White 10.3 0.29 774.87 20 96.013 
6 month White 10.27 0.27 774.25 25 95.897 
OXIRASE 
0 month White 7.6 0.57 721.65 11 98.934 
3 month White 7.2 0.58 720.54 12 98.254 
6 month White 7.19 0.52 720.20 12 97.890 
QUASH 
0 month White 6.6 0.39 772.65 25 96.340 
3 month White 6.36 0.42 773.54 26 96.043 
6 month White 6.25 0.42 773.20 26 95.740 
 
Table: 2 
Table 2 describes the results of the drug potency 
of different brands of Ciprofloxacin. All the 
selected brands met USP 24 requirements in 
spite of the appreciable differences among the % 
drug potency of various formulations. The Axcin 
indicated maximum drug potency (102%) and 
(101%) respectively while minimum potency  
 
 
 
was 93.07% which was shown by 
OXIRASE.The differences among the results 
showing the the drug potency may be due to the 
following reasons. 
(a) Manufacturing process variations. 
(b) Use of various quality and quantity 
of formulation materials and  
(c) Use of poor quality of raw materials 
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Table 2: Chemical Assay of Ciprofloxacin tablets 
FPP Absorbance (Mean)  
Sample  Standard %Q 
Axcin 1.178 1.17 102.320 
MYTIL 
 1.105 1.17 96.134 
NAFCIN 
 1.116 1.17 97.865 
OXIRASE 
 1.061 1.17 93.07 
QUASH 1.129 1.17 99.03 
                                      
Table 3 And Fig 1 to 3 show the results of 
the calibration curves of Ciprofloxacin HCl 
in D/W and in 0.1 N HCl. A prominent 
difference in the dissolution and solubility of 
Ciprofloxacin in D/W and 0.1 N HCl is 
obvious from the comparison of both the 
calibration curves, obtained from analysis of 
the similar concentrations of Ciprofloxacin 
HCl in D/W and in 0.1 N HCl solvents 
under similar conditions. Greater absorbance 
was observed for the concentration of 
Ciprofloxacin in 0.1 N HCl (solvent) as 
compared to the absorbance of the same 
concentration in D/W at same λmax 
(276nm).this confirms that dissolution and 
solubility of Ciprofloxacin in  0.1 N HCl (at 
pH 1.2) is greater than D/W. This difference 
was also demonstrated by the dissolution 
profiles of selected brands of Ciprofloxacin 
HCl in both the dissolution media (D/W and 
0.1 N HCl  
 
Table 3: Conc. Vs peak areas of Ciprofloxacin in  D/W and 0.1N HCl 
 
Sr.# Stock 
Soln(ml) 
Dilutions 
mg/ml 
Absorbance in D/W Absorbance 
In 0.1N HCl 
1 2.0 0.008 0.686 0.980 
2 2.5 0.010 0.863 1.218 
3 3 0.012 1.040 1.470 
4 3.5 0.014 1.217 1.708 
5 4 0.016 1.394 1.991 
6 4.5 0.018 1.572 2.208 
7 5 0.020 1.749 2.432 
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Fig.1:   Calibration curve of Ciprofloxacin HCl in D/W 
 
 
 
                    Fig.2: Calibration curve of Ciprofloxacin HCl in 0.1N HCl 
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Fig.3: Comparison b/w calibration curves of Ciprofloxacin HCl in D/W and 0.1 N HCl. 
 
The table 4 shows the results of the comparative 
dissolution of individual brands of Ciprofloxacin 
in D/W and 0.1 N HCl.  All the formulations 
dissolution profiles were found within the USP 
24 recommended range, in both the dissolution 
media with discernible variations among their 
profiles. Dissimilarity among the different 
formulations dissolution profiles within the 
same dissolution media were found. Two of the 
Five (40% sampled) brands of Ciprofloxacin 
(Axcin, Mytil,) and one out of the Five (20% 
sampled) brands showed very rapidly dissolving 
immediate release profile   by exhibiting >85% 
drug release within first 15 minutes in 0.1 N HCl 
while this was accomplished by one of Five 
(20%) brands of Ciprofloxacin (Axcin) in D/W. 
All other formulations of v showed 
comparatively weak dissolution profile. 
 
Table 4: Dissolution Data of Axcin at room temperature 
 
DW 
 0 month 3 month 6 month 
5 min 71.3719 71.3809 71.7645 
15 min 79.8957 80.9431 81.0321 
30 min 95.1005 95.2410 95.8965 
45 min 95.2053 95.8954 95.9785 
60 min 95.0717 95.9732 96.0132 
0.1 HCl 
 0 month 3 month 6 month 
5 min 80.8935 80.9785 81.0216 
15 min 88.9758 89.0214 89.1340 
30 min 97.4255 97.6532 97.7543 
45 min 97.9643 97.9865 98.0021 
60 min 97.6049 98.0145 98.1325 
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The disintegration profiles acquired from all 
brands after capacity at mimicked tropical 
conditions were found inside of the USP 
prescribed reach for in-vitro drug discharge 
.Moreover all the F.P.Ps showed a checked 
lessening with abnormal state of varieties among 
their in-vitro drug discharge profiles amid 
capacity at recreated tropical conditions. Which 
clarify the estimations of f2 for the 
disintegration information of individual brands 
furthermore indicate examination among the 
closeness component (f2) of chose definitions at 
3 months and 6 months at reenacted tropical 
capacity conditions. The f2 values computed for 
Mytil, Nafacin and OXIRASE were 67.2, 65.3, 
62.95 individually following 3 and 6 months 
stockpiling showing noticeable similitude in 
their disintegration profiles with the standard 
medication.Therefore disintegration qualities of 
these plans were considered pharmaceutically 
proportionate medication discharge profiles of 
standard medication (87).  
 
After capacity at reproduced tropical conditions 
for 6 months under both conditions, all plans 
demonstrated similitude (f2 >50) in the 
disintegration profile with that of the standard 
medication Axcin. The base contrast in the profile 
were watched for Oxrase (f2=36.61) individually. 
In addition, the varieties in the profile were an 
excess of higher after capacity at 40 °C ±2° 
RH:75%±5% when contrasted with that of the 
outcomes after capacity at 25 °C ±2°C/RH :60% 
±5% for 6 months. It unmistakably clarifies the 
more conspicuous impact of expansion 
temperature and relative stickiness amount in 
nature upon the soundness of the Ciprofloxacin 
(88).  
 
As it has been seen by Pecol et al. in 1999(89) 
that the nature of medications turns out to be less 
sure especially for poor populaces why should 
charmed lower evaluated drugs in an unregulated 
situation .For this situation, it is imperative that 
the medication administrative power ought to take 
the fundamental measure to guarantee that the 
medications accessible in the pharma business 
sector are persistently of good quality. The 
substance examine results on the substance of the 
API outlined this point of confinement was inside 
of the procurement prescribed by the USP for all 
F.P.Ps. The discoveries are like those delivered 
Abdi et al. in 1995 (90) on the nature of 
chloroquine tablets accessible on the pharma 
business sector of Tanzania, where all inspected 
F.P.Ps from 10 distinct makers were found inside 
of the scope of USP particulars of the concoction 
examine test. However a report was presented by 
Kibwage et al. in 1992 (91) delineated that 
roughly 45% of all the F.P.Ps inspected from the 
pharmaceutical business sector of Kenyan and 
dissected at the quality control lab of Daru were 
found of substandard quality as far as the 
substance of the API. Additionally another study 
was led by Shakoor et al. in 1997 (92) pointed on 
the vicinity of both fake and substandard 
medications on the pharma markets of Thai and 
Nigerai where 32 % of 89 tests did not go along 
the USP details of synthetic examine. These 
varieties in results can't be explained, taking into 
account the continuance of a fruitful medication 
control and observing framework. As it has been 
seen in numerous reports concerning the nature of 
medications in the creating nations. (93)  
 
A few studies have been portrayed in the writing 
audit on the soundness of the pharmaceutical 
measurement shapes under honest to goodness 
stockpiling environment in the tropics (94, 95, 
96). Every one of these reports have pointed on 
the substance strength of the medication. It is 
perceived that under states of hot moist 
temperature, the API might encounter 
polymorphic or precious stone changes, which 
reduce its characteristic solvency. In addition, 
there is probability of collaborations between 
excipient-excipient or excipient-drug connections 
to happen affected by hot sticky temperature, 
which understudy diminish the disintegration rate 
of a pharmaceutical dose shapes containing a 
synthetically stable medication (96). In the present 
study sensational changes in the disintegration 
conduct of a few definitions have been watched. 
The medication definition that fizzled the 
soundness test had a more than 40% decrease in 
the measure of medication discharged following 3 
and 6 months of security testing. It was unrealistic 
to distinguish the reason for the disappointment in 
disintegration of the plans, as the careful 
arrangement of the details was not accessible. It is 
realized that the unexpected communications 
among the elements of the measurement structure 
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occurring for a medication plan put away at high 
temperature and stickiness conditions are mind 
boggling and definition subordinate. (97)  
 
The F.P.Ps might have for instance disintegrants, 
which can detached its ability to swell on 
maturing or on revelation to high 
mugginess/temperature (98). For the details that 
did not go along the USP determinations of the 
disintegration test, no firm choice might be 
tackled its bioavailability profile. (97)  
 
Since numerous reports have portrayed on the 
instances of trial details with an essentially 
decreased in-vitro drug discharge attributes after 
maturing, however offering comparable 
bioavailability profiles to new definitions .Such 
cases have been watched for matured 
Nitrofurantoin cases (99). Conversely different 
studies directed with the outcomes that 
Nitrofurantioin tablet definitions upon 
introduction to stretch conditions offered a 
noteworthy reduction in-vitro drug discharge 
profiles furthermore an impressive decrease in 
their rate of retention (100). The inability to 
follow the USP disintegration details might be 
considered as a notice of an imminent 
bioavailability issue.  
 
The disintegration tests were skillful to separate 
low quality F.P.Ps amongst the examples that had 
surrendered the concoction test tests. Albeit all the 
F.P.Ps showed compound corruption after 
maturing yet a percentage of the details displayed 
maturing reduction in their disintegration conduct 
when contrasted with pioneer/standard references 
brand (Axcin).This impact was high up at high 
temperature and abnormal state of stickiness 
proportion (40 °C±2°/RH; 75%±5%) while at 
states of 25 °C±2°/RH;60%±5% it was 
moderately less lively. At first 62.5%(3/5) of the 
chose brands indicated disintegration profile like 
the standard detailing i.e f2 esteem ≥50 or near 50 
however upon introduction to reenacted tropical 
capacity conditions, this proportion was 
drastically decreased to 12.5%. This as well as 
one of the brands fizzled the disintegration test 
subsequent to being subjected to a dependability 
test at reproduced tropical conditions which 
affirms that increment in temperature and 
stickiness improve the rate of synthetic response 
(102). As identified with the administrative 
perspectives ,the WHO encourage a quickened 
soundness test under zone IV climatic conditions 
to be executed for all pharmaceutical 
measurements frames made arrangements for 
bringing into the worldwide pharmaceutical 
market(Matthews)(101) A steadiness test is 
proposed as a quality control apparatus that might 
be utilized to affirm if a dose structure/definition 
and the assembling process don't impact the 
adequacy and wellbeing of the item under the 
appropriation and capacity conditions .The 
breakdown of a few details to guarantee 
disintegration's standard particulars subsequent to 
being subjected to a dependability test at 
mimicked tropical capacity conditions guess that 
the medication plans are confused for promoting 
in nations with tropical atmosphere conditions, for 
example, Pakistan. Standard examining and 
observation of the quality and security in tropical 
states of the details on business sector by the 
administrative power ought to be idealistic as 
method for keeping the passageway to the 
business sector of pharma with 
CONCLUSION: 
During the collection of the samples, it was 
appeared that there are huge disparity between the 
price of innovator brand and their generic 
equivalents. It is very important to take essential 
measures aimed at to control and monitor the 
quality of the medicines, available in the phrma 
market. The in-vitro evaluation of 5 different 
F.P.Ps of Ciprofloxacin HCl film coated tablets 
available in the pharmaceutical market of Pakistan 
showed that all of brands of Ciprofloxacin 
satisfied the USP potency specifications and 
showed evidences of satisfactory initial in-vitro 
dissolution behavior. However, the dissolution 
characteristics after storage at simulated tropical 
conditions for 6 months, 2 of these F.P.Ps were 
not acceptable. The evaluation of the 
bioavailability of these formulations is optional to 
expound the effect of poor dissolution on its 
bioavailability 
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